Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA

被引：0
|
作者：
Samant, T. S. [1 ]
Struemper, H. [2 ]
Franzese, R. C. [1 ]
Goulooze, B. [3 ]
Muliaditan, M. [3 ]
Melhem, M. [4 ]
Ghosh, S. [1 ]
Fastenrath, M. [5 ]
Stjepanovic, N. [6 ]
Szijgyarto, Z. [7 ]
Rathi, C. [1 ]
Mantero, A. [1 ]
Hanafin, P. [1 ]
Zajic, S. [1 ]
Yanamandra, N. [1 ]
Chung, C-W.
Vlahovic, G.
机构：
[1] GSK, Collegeville, PA USA
[2] GSK, Durham, NC USA
[3] LAP&P Consultants, Leiden, Netherlands
[4] GSK, Waltham, MA USA
[5] GSK, London, England
[6] GSK, Baar, Switzerland
[7] GSK, Stevenage, Herts, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
基金：
芬兰科学院;
关键词：
mNSCLC; Tumor Size-Overall Survival Modeling; Clinical Pharmacology;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4.11E.28
引用
收藏
页码：S407 / S408
页数：2
相关论文
共 50 条
  • [21] Metastatic Non-Small Cell Lung Cancer to the Small Bowel
    Levy, Sara
    Shroff, Sagar
    Qayed, Emad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S421 - S421
  • [22] Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer
    J Cortes
    J Rodriguez
    J A Diaz-Gonzalez
    C Garzon
    A Gurpide
    L Arbea
    I Gil-Bazo
    V Navarro
    M Cambeiro
    A I Nicolas
    S Martin-Algarra
    J Garcia-Foncillas
    E Calvo
    British Journal of Cancer, 2002, 87 : 158 - 160
  • [23] Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer
    Cortes, J
    Rodriguez, J
    Diaz-Gonzalez, JA
    Garzon, C
    Gurpide, A
    Arbea, L
    Gil-Bazo, I
    Navarro, V
    Cambeiro, M
    Nicolas, A
    Martin-Algarra, S
    Garcia-Foncillas, J
    Calvo, E
    BRITISH JOURNAL OF CANCER, 2002, 87 (02) : 158 - 160
  • [24] Therapy of Metastatic Non-small Cell Lung Cancer
    Reinmuth, N.
    Groeschel, A.
    Schumann, C.
    Sebastian, M.
    Wiewrodt, R.
    Reck, M.
    PNEUMOLOGIE, 2016, 70 (09): : 567 - 578
  • [25] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [26] Chemotherapy for metastatic non-small cell lung cancer
    Pérol, M
    Moro-Sibilot, D
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : S131 - S136
  • [27] Phase 1 Study of Pembrolizumab and Stereotactic or Hypofractionated Radiation for Metastatic Non-small Cell Lung Cancer
    Tang, C.
    de Groot, P.
    Hess, K.
    Shabaan, S.
    Gomez, D. R.
    Chang, J. Y.
    Lin, S. H.
    Paraskevopoulos, T.
    Raju, U.
    Simon, G. R.
    Papadimitrakopoulou, V.
    Liao, Z.
    Fossella, F. V.
    Glisson, B. S.
    Komaki, R. U.
    Hahn, S. M.
    Heymach, J.
    Welsh, J. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S160 - S161
  • [28] Bone Metastases and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Pembrolizumab
    Das, P.
    Zhao, S.
    Wei, L.
    Miah, A.
    Li, M.
    Lopez, G.
    Patel, S.
    Johns, A.
    Grogan, M.
    Bertino, E.
    He, K.
    Shields, P.
    Carbone, D.
    Otterson, G.
    Presley, C.
    Owen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S293 - S293
  • [29] Safety, Tolerability and Clinical Activity of Selinexor in Combination with Pembrolizumab in Metastatic Non-small Cell Lung Cancer
    Altan, M.
    Tu, J.
    Milton, D. R.
    Yilmaz, B.
    Fossella, F. V.
    Mott, F. E.
    Blumenschein, G. R.
    Stephen, B. A.
    Karp, D. D.
    Naing, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S367 - S368
  • [30] Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer (MNSCLC) with Brain Metastases Treated with Pembrolizumab
    Sun, L.
    Davis, C.
    Marmarelis, M.
    Singh, A.
    Berman, A.
    Feigenberg, S.
    Levin, W.
    Bauml, J.
    Cohen, R.
    Langer, C.
    Aggarwal, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1131 - S1131
12345